R Lima e Silva, Y Kanan, AC Mirando, J Kim… - Science translational …, 2017 - science.org
Vascular endothelial growth factor (VEGF)–neutralizing proteins provide benefit in several retinal and choroidal vascular diseases, but some patients still experience suboptimal …
Natural products from plants, such as chemopreventive agents, attract huge attention because of their low toxicity and high specificity. The rational drug design in combination …
EM Bressler, J Kim, RB Shmueli… - … Research Part A, 2018 - Wiley Online Library
While poly (lactic‐co‐glycolic acid)‐block‐polyethylene glycol (PLGA‐PEG) nanoparticles (NPs) can encapsulate drug cargos and prolong circulation times, they show nonspecific …
E Lee, SJ Lee, JE Koskimaki, Z Han, NB Pandey… - Scientific reports, 2014 - nature.com
Metastasis is the main cause of mortality in cancer patients. Though there are many anti- cancer drugs targeting primary tumor growth, anti-metastatic agents are rarely developed …
Cooperation between VEGFR2 and integrin αVβ3 is critical for neovascularization in wound healing, cardiovascular ischemic diseases, ocular diseases, and tumor angiogenesis. In the …
Leading causes of vision loss include neovascular age-related macular degeneration (NVAMD) and macular edema (ME), which both require frequent intravitreal injections for …
AC Mirando, A Patil, CI Rafie, BJ Christmas… - …, 2020 - Taylor & Francis
Triple-negative breast cancer (TNBC) is a highly metastatic and aggressive disease with limited treatment options. Recently, the combination of the immune checkpoint inhibitor (ICI) …
AXT107, a collagen-derived peptide that binds integrins α v β 3 and α 5 β 1 with high affinity, suppresses vascular endothelial growth factor (VEGF) signaling, promotes angiopoietin 2 …
Triple-negative breast cancer (TNBC) is a particularly aggressive and invasive subtype of breast cancer that represents a major cause of death of women worldwide. Here we …